Key takeaways
Ipratropium/albuterol solution and albuterol inhaler are both medications used to help with breathing problems. They both contain albuterol, a short-acting beta-agonist (SABA) that helps open up your airways. Ipratropium/albuterol solution is specifically used for chronic obstructive pulmonary disease (COPD) and is inhaled through a nebulizer, while albuterol inhaler is used for asthma and can also prevent exercise-induced asthma. The albuterol inhaler is available in different forms, such as HFA inhalers and dry powder inhalers, and is typically used as needed for sudden breathing issues. Ipratropium/albuterol solution combines albuterol with ipratropium, a short-acting muscarinic antagonist (SAMA), and is used regularly, up to four times a day. The albuterol inhaler is available in both brand and generic forms, while ipratropium/albuterol solution is only available as a generic. Common side effects of ipratropium/albuterol solution include lung problems and sore throat, whereas albuterol inhaler can cause sore throat and throat irritation.
